{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:01:09Z","timestamp":1772136069902,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The burden of COVID-19 has been noted to be disproportionately greater in minority women, a population that is nevertheless still understudied in COVID-19 research. We conducted an observational study to examine COVID-19-associated mortality and cardiovascular disease outcomes after testing (henceforth index) among a racially diverse adult women veteran population. We assembled a retrospective cohort from a Veterans Affairs (VA) national COVID-19 shared data repository, collected between February and August 2020. A case was defined as a woman veteran who tested positive for SARS-COV-2, and a control as a woman veteran who tested negative. We used Kaplan\u2013Meier curves and the Cox proportional hazards model to examine the distribution of time to death and the effects of baseline predictors on mortality risk. We used generalized linear models to examine 60-day cardiovascular disease outcomes. Covariates studied included age, body mass index (BMI), and active smoking status at index, and pre-existing conditions of diabetes, chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), and a history of treatment with antiplatelet or anti-thrombotic drug at any time in the 2\u00a0years prior to the index date. Women veterans who tested positive for SARS-CoV-2 had 4 times higher mortality risk than women veterans who tested negative (Hazard Ratio 3.8, 95% Confidence Interval CI 2.92 to 4.89) but had lower risk of cardiovascular events (Odds Ratio OR 0.78, 95% CI 0.66 to 0.92) and developing new heart disease conditions within 60\u00a0days (OR 0.67, 95% CI 0.58 to 0.77). Older age, obesity (BMI\u2009&gt;\u200930), and prior CVD and COPD conditions were positively associated with increased mortality in 60\u00a0days. Despite a higher infection rate among minority women veterans, there was no significant race difference in mortality, cardiovascular events, or onset of heart disease. SARS-CoV-2 infection increased short-term mortality risk among women veterans similarly across race groups. However, there was no evidence of increased cardiovascular disease incidence in 60\u00a0days. A longer follow-up of women veterans who tested positive is warranted.<\/jats:p>","DOI":"10.1038\/s41598-021-88111-z","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T06:04:56Z","timestamp":1618812296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["COVID-19 associated mortality and cardiovascular disease outcomes among US women veterans"],"prefix":"10.1038","volume":"11","author":[{"given":"Shirling","family":"Tsai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramin","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica R.","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bala","family":"Ramanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel F.","family":"Heitjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey L.","family":"Hastings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Gregory","family":"Modrall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haekyung","family":"Jeon-Slaughter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,19]]},"reference":[{"key":"88111_CR1","unstructured":"Oppel, R. A. J., Gebeloff, R., Lai, K. K. R., Wright, W. & Smith, M. In New York Times https:\/\/www.nytimes.com\/interactive\/2020\/07\/05\/us\/coronavirus-latinos-african-americans-cdc-data.html (New York Times, 2020)."},{"key":"88111_CR2","unstructured":"Burton, A. & Fontana, F. In The Wall Street Journal https:\/\/www.wsj.com\/articles\/for-black-working-women-covid-19-has-been-a-heavy-burden-11601434755 (2020)."},{"key":"88111_CR3","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.12.20099135","author":"CT Rentsch","year":"2020","unstructured":"Rentsch, C. T. et al. Covid-19 by race and ethnicity: A national cohort study of 6 million United States veterans. medRxiv https:\/\/doi.org\/10.1101\/2020.05.12.20099135 (2020).","journal-title":"medRxiv"},{"key":"88111_CR4","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/s0140-6736(20)31189-2","volume":"395","author":"MJ Cummings","year":"2020","unstructured":"Cummings, M. J. et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: A prospective cohort study. Lancet 395, 1763\u20131770. https:\/\/doi.org\/10.1016\/s0140-6736(20)31189-2 (2020).","journal-title":"Lancet"},{"key":"88111_CR5","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1001\/jamainternmed.2020.3539","volume":"180","author":"G Grasselli","year":"2020","unstructured":"Grasselli, G. et al. Risk factors associated with mortality among patients with COVID-19 in Intensive Care Units in Lombardy, Italy. JAMA Intern. Med. 180, 1345\u20131355. https:\/\/doi.org\/10.1001\/jamainternmed.2020.3539 (2020).","journal-title":"JAMA Intern. Med."},{"key":"88111_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.3596","author":"S Gupta","year":"2020","unstructured":"Gupta, S. et al. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern. Med. https:\/\/doi.org\/10.1001\/jamainternmed.2020.3596 (2020).","journal-title":"JAMA Intern. Med."},{"key":"88111_CR7","doi-asserted-by":"publisher","first-page":"e2022310","DOI":"10.1001\/jamanetworkopen.2020.22310","volume":"3","author":"GN Ioannou","year":"2020","unstructured":"Ioannou, G. N. et al. Risk factors for hospitalization, mechanical ventilation, or death among 10 131 US veterans with SARS-CoV-2 infection. JAMA Netw. Open 3, e2022310. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.22310 (2020).","journal-title":"JAMA Netw. Open"},{"key":"88111_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3389\/fmed.2020.00459","volume":"7","author":"MJ Nasiri","year":"2020","unstructured":"Nasiri, M. J. et al. COVID-19 clinical characteristics, and sex-specific risk of mortality: Systematic review and meta-analysis. Front. Med. 7, 459\u2013459. https:\/\/doi.org\/10.3389\/fmed.2020.00459 (2020).","journal-title":"Front. Med."},{"key":"88111_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-020-00430-w","author":"E Klang","year":"2020","unstructured":"Klang, E. et al. Sex differences in age and comorbidities for COVID-19 mortality in urban New York City. SN Compr. Clin. Med. https:\/\/doi.org\/10.1007\/s42399-020-00430-w (2020).","journal-title":"SN Compr. Clin. Med."},{"key":"88111_CR10","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/s0140-6736(20)31748-7","volume":"396","author":"SS Bhopal","year":"2020","unstructured":"Bhopal, S. S. & Bhopal, R. Sex differential in COVID-19 mortality varies markedly by age. Lancet 396, 532\u2013533. https:\/\/doi.org\/10.1016\/s0140-6736(20)31748-7 (2020).","journal-title":"Lancet"},{"key":"88111_CR11","doi-asserted-by":"publisher","first-page":"e017013","DOI":"10.1161\/JAHA.120.017013","volume":"9","author":"AK Gupta","year":"2020","unstructured":"Gupta, A. K. et al. Current perspectives on coronavirus disease 2019 and cardiovascular disease: A white paper by the JAHA editors. J. Am. Heart. Assoc. 9, e017013\u2013e017013. https:\/\/doi.org\/10.1161\/JAHA.120.017013 (2020).","journal-title":"J. Am. Heart. Assoc."},{"key":"88111_CR12","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41569-020-0413-9","volume":"17","author":"M Nishiga","year":"2020","unstructured":"Nishiga, M., Wang, D. W., Han, Y., Lewis, D. B. & Wu, J. C. COVID-19 and cardiovascular disease: From basic mechanisms to clinical perspectives. Nat. Rev. Cardiol. 17, 543\u2013558. https:\/\/doi.org\/10.1038\/s41569-020-0413-9 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"88111_CR13","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/S0140-6736(20)30854-0","volume":"395","author":"A Banerjee","year":"2020","unstructured":"Banerjee, A. et al. Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: A population-based cohort study. Lancet 395, 1715\u20131725. https:\/\/doi.org\/10.1016\/S0140-6736(20)30854-0 (2020).","journal-title":"Lancet"},{"key":"88111_CR14","doi-asserted-by":"publisher","first-page":"e1003","DOI":"10.1016\/s2214-109x(20)30264-3","volume":"8","author":"A Clark","year":"2020","unstructured":"Clark, A. et al. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: A modelling study. Lancet Glob. Health 8, e1003\u2013e1017. https:\/\/doi.org\/10.1016\/s2214-109x(20)30264-3 (2020).","journal-title":"Lancet Glob. Health"},{"key":"88111_CR15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11606-013-2381-9","volume":"28","author":"VG Vimalananda","year":"2013","unstructured":"Vimalananda, V. G. et al. Cardiovascular disease risk factors among women veterans at VA Medical facilities. J. Gen. Intern. Med. 28, 517\u2013523 (2013).","journal-title":"J. Gen. Intern. Med."},{"key":"88111_CR16","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1056\/NEJMoa012573","volume":"346","author":"FA Lederle","year":"2002","unstructured":"Lederle, F. A. et al. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N. Engl. J. Med. 346, 1437\u20131444. https:\/\/doi.org\/10.1056\/NEJMoa012573 (2002).","journal-title":"N. Engl. J. Med."},{"key":"88111_CR17","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1056\/NEJMoa051255","volume":"352","author":"JD Blankensteijn","year":"2005","unstructured":"Blankensteijn, J. D. et al. Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms. N. Engl. J. Med. 352, 2398\u20132405. https:\/\/doi.org\/10.1056\/NEJMoa051255 (2005).","journal-title":"N. Engl. J. Med."},{"key":"88111_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1001\/archsurg.134.1.36","volume":"134","author":"J Gibbs","year":"1999","unstructured":"Gibbs, J. et al. Preoperative serum albumin level as a predictor of operative mortality and morbidity: Results from the National VA Surgical Risk Study. Arch. Surg. 134, 36\u201342. https:\/\/doi.org\/10.1001\/archsurg.134.1.36 (1999).","journal-title":"Arch. Surg."},{"key":"88111_CR19","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1161\/circulationaha.118.037748","volume":"139","author":"JK Han","year":"2019","unstructured":"Han, J. K., Yano, E. M., Watson, K. E. & Ebrahimi, R. Cardiovascular care in women veterans. Circulation 139, 1102\u20131109. https:\/\/doi.org\/10.1161\/circulationaha.118.037748 (2019).","journal-title":"Circulation"},{"key":"88111_CR20","doi-asserted-by":"publisher","first-page":"e015087","DOI":"10.1161\/JAHA.120.015087","volume":"9","author":"X Chen","year":"2020","unstructured":"Chen, X., Ramanan, B., Tsai, S. & Jeon-Slaughter, H. Differential impact of aging on cardiovascular risk in women military service members. J. Am. Heart Assoc. 9, e015087\u2013e015087. https:\/\/doi.org\/10.1161\/JAHA.120.015087 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"88111_CR21","unstructured":"Hastie, T. J. & Tibshirani, R. J. Generalized Additive Models (Chapman and Hall, 1999)."},{"key":"88111_CR22","doi-asserted-by":"publisher","first-page":"e2012270","DOI":"10.1001\/jamanetworkopen.2020.12270","volume":"3","author":"G Suleyman","year":"2020","unstructured":"Suleyman, G. et al. Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan detroit. JAMA Netw. Open 3, e2012270. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.12270 (2020).","journal-title":"JAMA Netw. Open"},{"key":"88111_CR23","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/s2213-8587(20)30271-0","volume":"8","author":"N Holman","year":"2020","unstructured":"Holman, N. et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: A population-based cohort study. Lancet Diabetes Endocrinol. 8, 823\u2013833. https:\/\/doi.org\/10.1016\/s2213-8587(20)30271-0 (2020).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"88111_CR24","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/s0140-6736(20)31187-9","volume":"395","author":"NM Kuderer","year":"2020","unstructured":"Kuderer, N. M. et al. Clinical impact of COVID-19 on patients with cancer (CCC19): A cohort study. Lancet 395, 1907\u20131918. https:\/\/doi.org\/10.1016\/s0140-6736(20)31187-9 (2020).","journal-title":"Lancet"},{"key":"88111_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/oby.23014","author":"S Czernichow","year":"2020","unstructured":"Czernichow, S. et al. Obesity doubles mortality in patients hospitalized for SARS-CoV-2 in Paris hospitals, France: A cohort study on 5795 patients. Obesity https:\/\/doi.org\/10.1002\/oby.23014 (2020).","journal-title":"Obesity"},{"key":"88111_CR26","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1038\/s41366-020-0648-x","volume":"44","author":"M Nakeshbandi","year":"2020","unstructured":"Nakeshbandi, M. et al. The impact of obesity on COVID-19 complications: A retrospective cohort study. Int. J. Obes. 44, 1832\u20131837. https:\/\/doi.org\/10.1038\/s41366-020-0648-x (2020).","journal-title":"Int. J. Obes."},{"key":"88111_CR27","doi-asserted-by":"publisher","first-page":"e13128","DOI":"10.1111\/obr.13128","volume":"21","author":"BM Popkin","year":"2020","unstructured":"Popkin, B. M. et al. Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships. Obes. Rev. 21, e13128. https:\/\/doi.org\/10.1111\/obr.13128 (2020).","journal-title":"Obes. Rev."},{"key":"88111_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijid.2016.06.015","volume":"49","author":"A Badawi","year":"2016","unstructured":"Badawi, A. & Ryoo, S. G. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): A systematic review and meta-analysis. Int. J. Infect. Dis. 49, 129\u2013133. https:\/\/doi.org\/10.1016\/j.ijid.2016.06.015 (2016).","journal-title":"Int. J. Infect. Dis."},{"key":"88111_CR29","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1002\/oby.22856","volume":"28","author":"IL Kruglikov","year":"2020","unstructured":"Kruglikov, I. L. & Scherer, P. E. The role of adipocytes and adipocyte-like cells in the severity of COVID-19 infections. Obesity 28, 1187\u20131190. https:\/\/doi.org\/10.1002\/oby.22856 (2020).","journal-title":"Obesity"},{"key":"88111_CR30","unstructured":"Department of Veterans Affairs. Women Veterans Report: The Past, Present and Future of Women Veterans. (2017)."},{"key":"88111_CR31","unstructured":"Department of Veterans Affairs. Minority Veterans Report. Match (National Center for Veterans Analysis and Statistics, 2017)."},{"key":"88111_CR32","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/s0140-6736(20)30823-0","volume":"395","author":"T Lancet","year":"2020","unstructured":"Lancet, T. The gendered dimensions of COVID-19. Lancet 395, 1168. https:\/\/doi.org\/10.1016\/s0140-6736(20)30823-0 (2020).","journal-title":"Lancet"},{"key":"88111_CR33","doi-asserted-by":"publisher","first-page":"e039849","DOI":"10.1136\/bmjopen-2020-039849","volume":"10","author":"FS Vahidy","year":"2020","unstructured":"Vahidy, F. S. et al. Racial and ethnic disparities in SARS-CoV-2 pandemic: Analysis of a COVID-19 observational registry for a diverse US metropolitan population. BMJ Open 10, e039849. https:\/\/doi.org\/10.1136\/bmjopen-2020-039849 (2020).","journal-title":"BMJ Open"},{"key":"88111_CR34","unstructured":"New York State Department of Health COVID-19 Fatalities. (Accessed May 1 2020) https:\/\/covid19tracker.health.ny.gov\/views\/NYS-COVID19-Tracker\/NYSDOHCOVID-19Tracker-Fatalities?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n."},{"key":"88111_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9082442","author":"DJ Alcendor","year":"2020","unstructured":"Alcendor, D. J. Racial disparities-associated COVID-19 mortality among minority populations in the US. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm9082442 (2020).","journal-title":"J. Clin. Med."},{"issue":"19","key":"88111_CR36","doi-asserted-by":"publisher","first-page":"11038","DOI":"10.1111\/jcmm.15599","volume":"24","author":"JT Moore","year":"2020","unstructured":"Moore, J. T., Pilkington, W. & Kumar, D. Diseases with health disparities as drivers of COVID-19 outcome. J. Cell. Mol. Med. 24(19), 11038\u201311045. https:\/\/doi.org\/10.1111\/jcmm.15599 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"88111_CR37","doi-asserted-by":"publisher","unstructured":"Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care (The National Academies Press, 2003) https:\/\/doi.org\/10.17226\/10260external.","DOI":"10.17226\/10260external"},{"key":"88111_CR38","doi-asserted-by":"publisher","first-page":"e2021892","DOI":"10.1001\/jamanetworkopen.2020.21892","volume":"3","author":"LS Mu\u00f1oz-Price","year":"2020","unstructured":"Mu\u00f1oz-Price, L. S. et al. Racial disparities in incidence and outcomes among patients with COVID-19. JAMA Netw. Open 3, e2021892\u2013e2021892. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.21892 (2020).","journal-title":"JAMA Netw. Open"},{"key":"88111_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.thromres.2020.05.018","volume":"192","author":"P Demelo-Rodr\u00edguez","year":"2020","unstructured":"Demelo-Rodr\u00edguez, P. et al. Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels. Thromb. Res. 192, 23\u201326. https:\/\/doi.org\/10.1016\/j.thromres.2020.05.018 (2020).","journal-title":"Thromb. Res."},{"key":"88111_CR40","unstructured":"Senst, B., Tadi, P., Goyal, A. & Jan, A. Hypercoagulability. [Updated 2021 Jan 31]. In: StatPearls (Treasure Island, FL: StatPearls Publishing) https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538251\/ (2021)."},{"key":"88111_CR41","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.thromres.2020.06.029","volume":"194","author":"MY Abou-Ismail","year":"2020","unstructured":"Abou-Ismail, M. Y., Diamond, A., Kapoor, S., Arafah, Y. & Nayak, L. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thromb. Res. 194, 101\u2013115. https:\/\/doi.org\/10.1016\/j.thromres.2020.06.029 (2020).","journal-title":"Thromb. Res."},{"key":"88111_CR42","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1016\/s2213-2600(20)30216-2","volume":"8","author":"RJ Jose","year":"2020","unstructured":"Jose, R. J. & Manuel, A. COVID-19 cytokine storm: The interplay between inflammation and coagulation. Lancet Respir. Med. 8, e46\u2013e47. https:\/\/doi.org\/10.1016\/s2213-2600(20)30216-2 (2020).","journal-title":"Lancet Respir. Med."},{"key":"88111_CR43","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/bjh.16727","volume":"189","author":"A Kollias","year":"2020","unstructured":"Kollias, A. et al. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Br. J. Haematol. 189, 846\u2013847. https:\/\/doi.org\/10.1111\/bjh.16727 (2020).","journal-title":"Br. J. Haematol."},{"key":"88111_CR44","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1001\/jama.2020.6019","volume":"323","author":"JM Sanders","year":"2020","unstructured":"Sanders, J. M., Monogue, M. L., Jodlowski, T. Z. & Cutrell, J. B. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A review. JAMA 323, 1824\u20131836. https:\/\/doi.org\/10.1001\/jama.2020.6019 (2020).","journal-title":"JAMA"},{"key":"88111_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15094","author":"SPH Alexander","year":"2020","unstructured":"Alexander, S. P. H. et al. A rational roadmap for SARS-CoV-2\/COVID-19 pharmacotherapeutic research and development: IUPHAR Review 29. Br. J. Pharmacol. https:\/\/doi.org\/10.1111\/bph.15094 (2020).","journal-title":"Br. J. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88111-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88111-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88111-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:03:24Z","timestamp":1670033004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88111-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,19]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["88111"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-88111-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-129409\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,19]]},"assertion":[{"value":"15 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8497"}}